healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program

Providers and Health Systems

Improve medication safety and health outcomes while reducing legal and financial burdens

Adverse drug events (ADEs) are considered a top four leading cause of death in the U.S. and a worldwide concern. This includes falls, emergency room visits, hospitalizations, morbidity, and even premature death. While many ADEs are preventable, the current healthcare delivery system was not designed to assess the hazard associated with polypharmacy and disease problem interactions.

GalenusRx empowers cutting-edge care that improves patient health outcomes and helps reduce the potential of legal and financial burdens by taking proactive, predictive, and preventive steps to mitigate the risk of medication-related problems. The GalenusRx APPRAISE™ (Actionable PolyPharmacy Risk Assessment Index for Safety and Equity) solution, designed to materially decrease the risk of ADEs, supports providers with the information needed to assess and adjust medication regimens to directly mitigate the probability of harm while improving efficacy.

1: Bates et al. (2023) The Safety of Inpatient Health Care. N Engl J Med; 388:142-153. https://www.nejm.org/doi/full/10.1056/NEJMsa2206117

Introducing the next generation of precision medicine

With clinician-informed machine learning, the APPRAISE simultaneously assesses drug-drug, multi-drug, drug-gene, drug-food, and drug-disease interactions to identify and resolve medication safety concerns for every patient.

The APPRAISE identifies the level of concern associated with a patient’s medication regimen, based on potential ADEs including falls, emergency room visits, hospitalizations, morbidity, and even premature death. The platform pinpoints medications with concern allowing healthcare providers to simulate changes to a patient’s medication regimen. These changes can include time of administration, dosage, starting a therapy, or discontinuing a therapy.

Personalized, precision medication safety technology for better patient outcomes

GalenusRx assists healthcare providers and their patients in optimizing medication regimens and significantly reducing the risk of preventable ADEs. The APPRAISE solution provides unparalleled clinical decision support for precision medication safety and an optimized medication regimen for every patient. Documented outcomes include reduced healthcare costs and lowered risk of adverse drug events such as falls, emergency room visits, hospitalizations, morbidity, and even premature death.

Founded in 2023 by a team of internationally recognized healthcare leaders, GalenusRx is the world’s most advanced medication safety assessment organization.

Subscribe to our newsletter

Site designed and managed by